Deciphering drug action and escape pathways: An example on nasopharyngeal carcinoma

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 5462 LNBI, Issue , 2009, Pages 199-210

  Difeng, Dong ^a   Chun Ying, Cui ^b   Benjamin, Mow ^c   Limsoon, Wong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c West Clinic Excellence Cancer Center   (Singapore)

Author keywords

CYC202; Drug pathway; Gene expression; NPC

Indexed keywords

BIOLOGICAL PATHWAYS; CYC202; DRUG ACTION; DRUG PATHWAY; GENE EXPRESSION DATA; GENE EXPRESSION DATASETS; NASOPHARYNGEAL CARCINOMA; NPC; PATHWAY IDENTIFICATION; POST TREATMENT; TREATMENT OUTCOMES;

BIOACTIVITY; BIOLOGY; DRUG THERAPY; GENE EXPRESSION;

BIOINFORMATICS;

EID: 68249123079     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-642-00727-9_20     Document Type: Conference Paper

References (28)

1. Alvi, A., Austen, B., Weston, V., et al.: A novel CDK inhibitor, CYC202 (Rroscovitine), overcomes the defect in p53-independent apoptosis in B-CLL by downregulation of genes involved in transcription regulation and survival. al 105, 4484-4491 (2005)
2. Doniger, S.W., Salomonis, N., Dahlquist, K.D., et al.: MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biology 4(1), R7 (2003)
3. Draghici, S., Khatri, P., Tarca, A., et al.: A systems biology approach for pathway level analysis. Genome Research 17(10), 1537-1545 (2007)
4. Guo, Z., Li, Y., Gong, X., et al.: Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network. Bioinformatics 23, 2121-2128 (2007)
5. Herrington, H.: Controlling the false discovery rate in multiple hypothesis testing, http://www.unt.edu/benchmarks/archives/2002/april02/rss.htm
6. Ideker, T., Ozier, O., Schwikowski, B., Siegel, A.F.: Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18(suppl. 1), S233-S240 (2002)
7. Kanehisa, M., Goto, S., Kawashima, S., Nakaya, A.: The KEGG database at GenomeNet. Nucleic Acids Research 30(1), 42-46 (2002)
8. Lacrima, K., Valentini, A., Lambertini, C., et al.: In vitro activity of cyclindependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas. Annals of Oncology 16, 1169-1176 (2005)
9. Lam, L., Pickeral, O., Peng, A., et al.: Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biology 2(10), research004 (2001)
10. McClue, S., Blake, D., Clarke, R., et al.: In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-ROSCOVITINE). International Journal of Cancer 102, 463-468 (2002)
11. Meijer, L., Borgne, A., Mulner, O., et al.: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinase cdc2, cdk2 and cdk5. European Journal of Biochemistry 243, 527-536 (1997)
12. Pathmanathan, R., Prasad, U., Sadler, R., et al.: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. The New England Journal of Medicine 333, 693-698 (1995)
13. Pui, C., Evans, W.: Acute lymphoblastic leukemia. New England Journal of Medicine 339, 605-615 (1998)
14. Raje, N., Kumar, S., Hideshima, T., et al.: Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via downregulation of MCL1 in multiple myeloma. Blood 106, 1042-1047 (2005)
15. Shi, W., Bastianutto, C., Li, A., et al.: Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. International Journal of Cancer 119, 2467-2475 (2006)
16. Smith, P., Yue, E.: Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents. Taylor and Francis Group, Abington (2006)
17. Soh, D., Dong, D., Guo, Y., Wong, L.: Enabling more sophisticated gene expression analysis for understanding diseases and optimizing treatments. ACM SIGKDD Explorations 9, 3-14 (2007)
18. Subramanian, A., Tamayo, P., Mootha, V., et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Science of the United States of America 102, 15545-15550 (2005)
19. Sultanem, K., Shu, H.K., Xia, P., et al.: Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California, San Francisco experience. International journal of radiation oncology, biology, physics 48, 711-722 (2000)
20. Tan,W., Dong, D., Loh, M., et al.: Pathway determinants of 5-Fluorouracil activity. Poster. In: 20th EORTC-NCI-AACR symposium on Molecular targets and Cancer Therapeutics (2008)
21. Tsao, S., Tramoutanis, G., Dawson, C., et al.: The significance of LMP1 expression in nasopharyngeal carcinoma. Cancer Biology 12, 473-487 (2002)
22. Whittaker, S., Walton, M., Garrett, M., Workman, P.: The cyclin-dependent kinase inhibitor CYC202 (R-Roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of cyclin D1, and activates the mitogen-activated protein kinase pathway. Cancer Research 64, 262-272 (2004)
23. Yeoh, E., Ross, M., Shurtleff, S., et al.: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133-143 (2002)
24. Yu, M., Yuan, J.: Epidemiology of nasopharyngeal carcinoma. Seminars in Cancer Biology 12, 421-429 (2002)
25. Zeeberg, B.R., Feng, W., Wang, G., et al.: GoMiner: A resource for biological interpretation of genomic and proteomic data. Genome Biology 4(4), R28 (2003)
26. Zien, A., Kuffner, R., Zimmer, R., Lengauer, T.: Analysis of gene expression data with pathway scores. Proceedings of International Conference on Intelligent Systems for Molecular Biology 8, 407-417 (2000)
27. Pathway Ingenuity database, http://www.ingenuity.com/
28. WikiPathways, http://www.wikipathways.org/index.php/WikiPathways